The My Seizure Gauge project reports significant progress in gathering data for the development and validation of a noninvasive, wearable biosensor system for forecasting seizures.
Compared to nonhormonal contraception, hormonal contraception appears to pose a greater risk for increased seizure frequency in women with epilepsy.
This study described data collected from patients who self-selected to participate in the Cleveland Clinic Epilepsy Center’s virtual follow-up program.
Patients with sepsis, particularly younger patients and those with CKD, may be at an elevated risk for new-onset epilepsy.
Children with pediatric epilepsy who undergo surgery may experience long-term changes in verbal and nonverbal IQ.
Researchers find qEG may provide adequate reassurance that an asymptomatic infant with a normal qEEG will not develop SWS.
Using artificial tools to collect and analyze conversations and comments about epilepsy posted online, researchers revealed that 7.8% of all posts by teenagers with epilepsy were related to suicide, compared with 3.2% of adult posts.
Poor seizure control, lack of breastfeeding education from a neurologist or lactation consultant, are factors contributing to lower breastfeeding rates in women with epilepsy, compared with the general population.
Investigators report cardiac arrhythmias with or without apnea among patients with epilepsy are associated with increased mortality risk.
Researchers found hypertension is associated with a 2.5-fold increased risk for developing epilepsy in older age, a risk that may be mitigated by hypertension treatment.
Formulation of purified cannabidiol may offer patients with tuberous sclerosis complex a new treatment option for seizures.
Children who suffer from infantile spasms (IS) may be at increased risk for developing autism spectrum disorder (ASD), but very few of their siblings are at risk for epilepsy or ASD, according to study results presented at the American Epilepsy Society 2019 Annual Meeting, held in Baltimore, Maryland from December 6 to 10. Previous studies…
Researchers found once-daily eslicarbazepine was effective, well-tolerated, and associated with improvements in HRQoL in pateints with focal seizures.